Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in by Nowak, Anna K, Prof, Lesterhuis, W Joost, PhD, Kok, Peey-Sei, MBBCh, Brown, Chris, MBiostat, Hughes, Brett GM, MBBS, Karikios, Deme J, PhD, John, Thomas, PhD, Kao, Steven C-H, PhD, Leslie, Connull, MBBS, Cook, Alistair M, PhD, Pavlakis, Nick, MBBS, Briscoe, Karen, MBBS, O'Byrne, Kenneth J, Prof, Karapetis, Christos S, Prof, Lam, Wei-Sen, MBBS, Langford, Ailsa, BSc, Yip, Sonia, PhD, Stockler, Martin R, MBBS

Get full text

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials by Drilon, Alexander, MD, Siena, Salvatore, Prof, Dziadziuszko, Rafal, MD, Barlesi, Fabrice, MD, Krebs, Matthew G, MD, Shaw, Alice T, Prof, de Braud, Filippo, Prof, Rolfo, Christian, MD, Ahn, Myung-Ju, MD, Wolf, Jürgen, Prof, Seto, Takashi, MD, Cho, Byoung Chul, Prof, Patel, Manish R, MD, Chiu, Chao-Hua, MD, John, Thomas, MD, Goto, Koichi, MD, Karapetis, Christos S, Prof, Arkenau, Hendrick-Tobias, MD, Kim, Sang-We, MD, Ohe, Yuichiro, MD, Li, Yu-Chung, MD, Chae, Young K, MD, Chung, Christine H, Prof, Otterson, Gregory A, Prof, Murakami, Haruyasu, MD, Lin, Chia-Chi, MD, Tan, Daniel S W, MD, Prenen, Hans, Prof, Riehl, Todd, PharmD, Chow-Maneval, Edna, PhD, Simmons, Brian, PharmD, Cui, Na, PhD, Johnson, Ann, MS, Eng, Susan, PharmD, Wilson, Timothy R, PhD, Doebele, Robert C, MD

Get full text